NCT02198352View on ClinicalTrials.gov

Study to Determine Tolerability After Intravenous Administration of BIBN 4096 BS in Healthy Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

June 30, 1998

Primary Completion Date

August 31, 1998

Conditions
Healthy
Interventions
DRUG

BIBN 4096 BS - in single rising doses

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY